Cellular Biomedicine Group, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Cellular Biomedicine Group, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Cellular Biomedicine Group, Inc..